Living with Neuroendocrine TumorsPeople with neuroendocrine tumors can lead meaningful, active, productive lives. Learn how you can make the most of every day. Managing NET symptoms Eating right Being active, staying safe Managing emotions Finding support See how others live with NETs made one or more lifestyle changes due to NETs2 0 % report general fatigue/muscle weakness2 0 % experienced diarrhea2 0 % The latest in NETRF News Advancing Understanding of Multiple Endocrine Neoplasia (MEN): A Q&A With John Metzcar We recently spoke with John Metzcar, PhD, president of AMEND USA, neuroendocrine cancer patient and Tracing the Roots of Small-Intestinal NETs By Anna Greene, PhD, Chief Scientific Officer, Neuroendocrine Tumor Research Foundation At NETRF, we often NETRF Clinical Trials Roundup, July 2026: New CAR T-Cell, Radiopharmaceutical, and DLL3-Targeted Approaches in NETs and NECs By Anna C. Greene, PhD, NETRF Chief Scientific Officer Clinical trial news in neuroendocrine cancer Browse our Youtube Channel Video Library Subscribe to NETRF Podcast Attend a NET patient conference Patient Events Find support groups in your area Check out patient advocacy groups 2Singh S, Granberg D, Wolin E, et al. Patient-reported burden of a neuroendocrine tumor (NET) diagnosis: results from the first global survey of patients with NETs. J Glob Oncol. 2016;2(1):43-53.
Advancing Understanding of Multiple Endocrine Neoplasia (MEN): A Q&A With John Metzcar We recently spoke with John Metzcar, PhD, president of AMEND USA, neuroendocrine cancer patient and
Tracing the Roots of Small-Intestinal NETs By Anna Greene, PhD, Chief Scientific Officer, Neuroendocrine Tumor Research Foundation At NETRF, we often
NETRF Clinical Trials Roundup, July 2026: New CAR T-Cell, Radiopharmaceutical, and DLL3-Targeted Approaches in NETs and NECs By Anna C. Greene, PhD, NETRF Chief Scientific Officer Clinical trial news in neuroendocrine cancer